Avidian Wealth Solutions LLC Purchases Shares of 2,226 iShares Biotechnology ETF (NASDAQ:IBB)

Avidian Wealth Solutions LLC acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 2,226 shares of the financial services provider’s stock, valued at approximately $302,000.

Several other institutional investors have also recently made changes to their positions in the business. Jacobi Capital Management LLC lifted its stake in iShares Biotechnology ETF by 3.7% in the 3rd quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock worth $310,000 after purchasing an additional 91 shares in the last quarter. PFG Investments LLC lifted its position in shares of iShares Biotechnology ETF by 4.8% in the third quarter. PFG Investments LLC now owns 2,013 shares of the financial services provider’s stock worth $246,000 after buying an additional 93 shares in the last quarter. Huntington National Bank boosted its stake in iShares Biotechnology ETF by 7.4% during the third quarter. Huntington National Bank now owns 1,450 shares of the financial services provider’s stock valued at $177,000 after buying an additional 100 shares during the last quarter. HB Wealth Management LLC grew its holdings in iShares Biotechnology ETF by 5.9% during the 4th quarter. HB Wealth Management LLC now owns 1,892 shares of the financial services provider’s stock valued at $257,000 after buying an additional 105 shares in the last quarter. Finally, Peterson Wealth Management grew its holdings in iShares Biotechnology ETF by 2.9% during the 3rd quarter. Peterson Wealth Management now owns 3,743 shares of the financial services provider’s stock valued at $458,000 after buying an additional 106 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.0 %

Shares of IBB opened at $133.02 on Tuesday. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The business’s 50 day simple moving average is $133.49 and its 200-day simple moving average is $130.23.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.